Most bought healthcare stocks in Q3 2022
See which Healthcare stocks institutional investors increased the most in Q3 2022, measured as net growth in reported share positions from Q2 2022 into Q3 2022. Notable additions at the top of this list include HALEON PLC-ADR (HLN), GSK PLC-SPON ADR (GSK), TREVI THERAPEUTICS INC (TRVI), AVANTOR INC (AVTR). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| HLN | HALEON PLC-ADR | 78,077,592 | $9.25M | 7 | 0 | 0 | 0 | 7 |
| GSK | GSK PLC-SPON ADR | 68,333,323 | $2.21M | 6 | 0 | 1 | 0 | 7 |
| TRVI | TREVI THERAPEUTICS INC | 4,667,687 | $7.00K | 1 | 1 | 0 | 0 | 2 |
| AVTR | AVANTOR INC | 4,350,737 | -$2.72M | 1 | 5 | 2 | 0 | 8 |
| ELAN | ELANCO ANIMAL HEALTH INC | 3,844,754 | -$1.55M | 1 | 3 | 2 | 0 | 6 |
| ABT | ABBOTT LABORATORIES | 3,587,243 | -$11.54M | 1 | 4 | 7 | 0 | 17 |
| BFLY | BUTTERFLY NETWORK INC | 2,710,879 | $103.97K | 0 | 2 | 2 | 0 | 4 |
| EXAS | EXACT SCIENCES CORP | 2,621,445 | -$1.72M | 1 | 2 | 1 | 0 | 4 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 2,283,821 | -$150.04K | 0 | 1 | 1 | 0 | 2 |
| AGL | AGILON HEALTH INC | 2,241,834 | $63.93K | 0 | 1 | 0 | 1 | 1 |
| NEOG | NEOGEN CORP | 1,901,833 | $385.00K | 2 | 1 | 0 | 0 | 3 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 1,793,838 | -$5.92K | 1 | 1 | 1 | 0 | 3 |
| EWTX | EDGEWISE THERAPEUTICS INC | 1,707,597 | $21.99K | 0 | 2 | 0 | 0 | 2 |
| SIGA | SIGA TECHNOLOGIES INC | 1,703,977 | -$119.31K | 0 | 1 | 0 | 1 | 1 |
| PFE | PFIZER INC | 1,691,318 | -$77.38M | 1 | 5 | 12 | 2 | 19 |
| ILMN | ILLUMINA INC | 1,679,219 | -$5.70M | 0 | 3 | 2 | 1 | 5 |
| CDNA | CAREDX INC | 1,649,060 | -$9.39K | 0 | 2 | 1 | 0 | 3 |
| AKBA | AKEBIA THERAPEUTICS INC | 1,534,127 | $431 | 0 | 1 | 0 | 0 | 1 |
| SENS | SENSEONICS HOLDINGS INC | 1,285,888 | $1.87K | 0 | 1 | 0 | 0 | 1 |
| APLS | APELLIS PHARMACEUTICALS INC | 1,267,554 | -$364.94K | 2 | 0 | 0 | 1 | 2 |
| CPRX | CATALYST PHARMACEUTICALS INC | 1,190,900 | -$6.71K | 0 | 1 | 0 | 1 | 1 |
| ELV | ELEVANCE HEALTH INC | 1,122,443 | -$5.51M | 1 | 2 | 10 | 1 | 15 |
| VERV | VERVE THERAPEUTICS INC | 1,048,535 | $80.99K | 0 | 1 | 0 | 1 | 1 |
| TXG | 10X GENOMICS INC-CLASS A | 972,988 | -$258.13K | 0 | 2 | 1 | 0 | 3 |
| BBIO | BRIDGEBIO PHARMA INC | 953,500 | $32.73K | 0 | 1 | 0 | 0 | 2 |
| VIR | VIR BIOTECHNOLOGY INC | 949,894 | $458 | 0 | 1 | 1 | 0 | 2 |
| NVAX | NOVAVAX INC | 855,747 | -$4.62M | 1 | 1 | 1 | 0 | 3 |
| SDGR | SCHRODINGER INC | 821,273 | -$2.26K | 0 | 2 | 1 | 0 | 4 |
| XRAY | DENTSPLY SIRONA INC | 793,611 | -$1.56M | 2 | 2 | 1 | 0 | 5 |
| CHRS | COHERUS BIOSCIENCES INC | 733,375 | $8.12K | 0 | 1 | 1 | 0 | 2 |
| FATE | FATE THERAPEUTICS INC | 718,805 | -$29.71K | 1 | 1 | 1 | 0 | 3 |
| ORGO | ORGANOGENESIS HOLDINGS INC | 710,736 | $571 | 0 | 1 | 1 | 0 | 2 |
| MNKD | MANNKIND CORP | 683,450 | $1.60K | 0 | 1 | 0 | 0 | 1 |
| MREO | MEREO BIOPHARMA GROUP PL-ADR | 624,705 | $380 | 0 | 1 | 0 | 0 | 1 |
| LLY | ELI LILLY & CO | 601,717 | $5.06M | 1 | 5 | 4 | 0 | 11 |
| HCAT | HEALTH CATALYST INC | 578,743 | $3.49K | 1 | 3 | 0 | 0 | 4 |
| EHAB | ENHABIT INC | 570,269 | $109.39K | 4 | 0 | 0 | 0 | 4 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 534,901 | -$31.90K | 0 | 1 | 1 | 0 | 3 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 531,023 | $22.43K | 0 | 1 | 1 | 1 | 2 |
| CMPS | COMPASS PATHWAYS PLC | 513,490 | -$7.04K | 1 | 1 | 1 | 0 | 3 |
| SGRY | SURGERY PARTNERS INC | 485,912 | $1.54K | 0 | 2 | 0 | 0 | 2 |
| LXRX | LEXICON PHARMACEUTICALS INC | 481,375 | $1.16K | 1 | 0 | 0 | 0 | 1 |
| SRPT | SAREPTA THERAPEUTICS INC | 476,769 | -$232.94K | 0 | 1 | 2 | 0 | 3 |
| ASRT | ASSERTIO HOLDINGS INC | 470,446 | $567 | 0 | 2 | 0 | 0 | 2 |
| NRIX | NURIX THERAPEUTICS INC | 462,697 | $8.36K | 0 | 1 | 1 | 0 | 2 |
| MYGN | MYRIAD GENETICS INC | 454,277 | $10.48K | 0 | 2 | 0 | 0 | 2 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 438,900 | $5.79K | 0 | 1 | 0 | 0 | 1 |
| ACHC | ACADIA HEALTHCARE CO INC | 417,023 | $75.53K | 1 | 1 | 2 | 0 | 4 |
| IART | INTEGRA LIFESCIENCES HOLDING | 415,538 | -$10.77K | 0 | 2 | 1 | 0 | 3 |
| TWST | TWIST BIOSCIENCE CORP | 409,887 | $46.65K | 0 | 2 | 0 | 0 | 2 |
Frequently asked questions about Most bought healthcare stocks in Q3 2022
What are the most bought Healthcare stocks in Q3 2022?
The most bought healthcare stocks in Q3 2022 are those with the largest increase in reported share counts across institutional investors compared to Q2 2022, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q3 2022?
Among filers in this sector, net additions were largest in companies such as HALEON PLC-ADR (HLN), GSK PLC-SPON ADR (GSK), TREVI THERAPEUTICS INC (TRVI), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2022).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.